A Phase III Randomized Trial Comparing Efficacy, Safety, and Immunogenicity of ZRC-3285 vs. Eylea(®) in Patients with Wet Age-Related Macular Degeneration
一项比较 ZRC-3285 与 Eylea® 在湿性年龄相关性黄斑变性患者中的疗效、安全性和免疫原性的 III 期随机试验
期刊:Ophthalmology and Therapy
影响因子:3.2
doi:10.1007/s40123-025-01299-5
Bansal, Mudit; Singh, Punit; Mehta, Ruchi K; Laul, Rohit Sanjay; Rana, Parth; Shah, Urmil; Vohra, Rajpal; Desai, Shachi; Bhomaj, Sharad; Patwardhan, Sourabh; Manoher, Jaishri Murli; Sapar, Anjali; Parwal, Sandeep; Amabde, Ajay Kartik; Shroff, Rahul; Natesh, Sribhargava; Biswas, Rupak Kanti; D, Lional Raj; Sinha, Bibhuti P; C K, Minija; Patel, Ekta; Kamble, Ashish; Bhende, Pramod; Patil, Sandeep; Shah, Anup; Narula, Ritesh; Kumari, Bandana; Bathula, Lokesh; Kirtane, Sandip; Darji, Bhargav; Doshi, Maulik; Parmar, Deven
